BridgeBio Oncology Therapeutics (BBOT) Accounts Payables (2024 - 2026)

BridgeBio Oncology Therapeutics (BBOT) posted Accounts Payables of $12.1 million for Q1 2026, up 779.91% sequentially from $1.4 million in Q4 2025.

BridgeBio Oncology Therapeutics (BBOT) Accounts Payables (2024 - 2026) Analysis & Trends

BridgeBio Oncology Therapeutics has reported Accounts Payables for 3 years, with the latest figure at $12.1 million in Q1 2026.

Quarterly Accounts Payables changed N/A year-over-year to $12.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.1 million (changed N/A YoY) and the FY2025 annual result came in at $1.4 million, down 55.3% from the prior year.
Accounts Payables grew to $12.1 million in Q1 2026 per BBOT's latest filing, from $1.4 million in the prior quarter.
Over five years, Accounts Payables peaked at $12.1 million in Q1 2026 and troughed at $9687.0 in Q1 2024.
A 3-year average of $3.8 million and a median of $2.8 million in 2024 frame the typical range for Accounts Payables.
The widest YoY moves for Accounts Payables: up 55.3% in 2025, down 55.3% in 2025.
Over 3 years, Accounts Payables stood at $3.1 million in 2024, then slumped by 55.3% to $1.4 million in 2025, then soared by 779.91% to $12.1 million in 2026.
According to Business Quant data, Accounts Payables over the past three periods registered $12.1 million, $1.4 million, and $3.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Accounts Payables (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	429.50 Mn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	1.16 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	1.52 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	88.42 Mn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	470.30 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	3.05 Mn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	35.57 Mn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	108.02 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	428.93 Mn
10	BridgeBio Oncology Therapeutics	726.38 Mn	500.67 Mn	-	6.73 Mn

Download Data